Louis Cai, MD
Ophthalmology · Sunnyvale
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 25
- 5 carriers
- Office
- 1
Offices
1 location
Hospitals listed: Good Samaritan Hospital. That is not proof they admit you there this week.
Plans that list them
25 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cai’s office at (408) 540-3559 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
25 of 25 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
State licence records
1 licence
- Florida ME154746Medical Doctor · since 2022 · expires 2026-01-31ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
School, training and certification
2 placements
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Education
- University of Miami2014–2018
Residency and fellowship
- Wills Eye Hospital, OPHTHALMOLOGYPhiladelphia, PA · 2019–2022
- UCF College of Medicine / HCA, TRANSITIONAL YEAROcala, FL · 2018–2019
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Good Samaritan HospitalSan Jose, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of HCA Healthcare, which runs 185 hospitals in 19 statesPatients rate it 2 of 5 · 67% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.337, Oct 2024 – Sep 2025
See every measure and the patient survey for Good Samaritan Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 1 worse of 8 measures. Readmissions: 0 better, 5 the same, 4 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.337 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.75 (0 to 1.67) · 1,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.54 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 143.59 (98.7 to 188.49) · 98 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.7 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 100 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.7 · 270 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 573 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 820 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.5 · 482 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.3 · 3,711 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.12 (0 to 0.3) · 8,866 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 9,051 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.65 (0.74 to 4.56) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.8 (0.21 to 3.39) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.33 (0.88 to 3.78) · 1,836 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.73 (0 to 13.46) · 669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.58 (3.96 to 11.19) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.59 (0.13 to 3.04) · 496 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.27 (0 to 0.87) · 7,373 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 152 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.08 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.542 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.484 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.565 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 327 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 24.2 · 703 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 61.1 · 289 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 36.3 · 665 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 25.4 · 856 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19 · 978 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.3 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 135 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.8 (10.1 to 18.6) · 129 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 531 cases | No different | Jan 2024 – Dec 2024 |
What patients said (704 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 71% |
| Staff "always" explained | 54% |
| Yes, staff "did" give patients this information | 83% |
| Yes, staff "did" give patients information about help after discharge | 81% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 69% |
| Doctors "always" treated them with courtesy and respect | 78% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 38% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 40% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$246,865
Medicare paid this office $246,865 for 382 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Injection, faricimab-svoa, 0.1 mg | 51 | $109,601 | None |
| Established patient complete exam of visual system | 177 | $22,117 | $116 |
| Injection, aflibercept, 1 mg | 13 | $19,333 | None |
| New patient visit (45+ min) | 106 | $15,974 | $151 |
| Imaging of retina | 338 | $15,709 | $38 |
See all 12 services
| Injection, faricimab-svoa, 0.1 mg | 51 | $109,601 | None |
| Established patient complete exam of visual system | 177 | $22,117 | $116 |
| Injection, aflibercept, 1 mg | 13 | $19,333 | None |
| New patient visit (45+ min) | 106 | $15,974 | $151 |
| Imaging of retina | 338 | $15,709 | $38 |
| Injection of drug into eye | 106 | $15,130 | $111 |
| Established patient problem focused exam of visual system | 33 | $3,458 | $84 |
| New patient complete exam of visual system | 18 | $2,211 | $123 |
| Emergency department visit with low level of medical decision making | 29 | $1,564 | $54 |
| Compounded drug, not otherwise classified | 16 | $1,548 | None |
| 2d ultrasound scan of eye tissue and structures | 14 | $824 | $46 |
| Photography of the retina | 13 | $455 | $35 |
Procedures Medicare counted
| Cataract surgery | 1-10 | None |
Who their Medicare patients are
382 Original Medicare patients in 2024. Average age 76 · Under 65 5% · 85 and older 15% · Women 60% · Also on Medicaid 35% · Health risk score 1.44. Above the middle of the specialty; the typical ophthalmology clinician is at 1.16.
Conditions among them: High blood pressure 75% · Diabetes 42% · Chronic kidney disease 27% · Coronary heart disease 25% · Heart failure 16% · Atrial fibrillation 15% · Depression 14% · Cancer 12% · COPD 12% · Dementia 7% · Stroke 7%.
The office billed $911,238, Medicare allowed $313,268 and paid $246,865; for 5,353 services of 38 kinds; $147,578 of it was for drugs given in the office and $99,287 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 382 | 5,353 | 76 | 1.44 | $911,238 | $246,865 |
| 2023 | 83 | 85 | 74 | 1.50 | $24,393 | $5,196 |
| 2022 | 27 | 27 | 73 | 1.30 | $6,002 | $1,524 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 1 service
| Emergency department visit with low level of medical decision making | 75 | $4,574 | $60 |
2022: 1 service
| Emergency department visit with low level of medical decision making | 19 | $1,177 | $62 |
Medicaid work
$10,731 in 2024
Medicaid paid $10,731 for 266 billed services this clinician did in 2024, up to 47 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 89 | $6,224 |
| Computerized ophthalmic diagnostic imaging (eg, optical coherence tomography [OCT]), posterior segment, with interpretation and report, unilateral or bilateral; retina | 104 | $1,661 |
| New patient visit (45+ min) | 21 | $1,594 |
| OPH SVCS MEDICAL XM&EVAL COMPRE EST PT 1/>VST | 52 | $1,252 |
| 2024 | 266 | 4 | 47 | $10,731 |
| 2023 | 329 | 2 | 44 | $19,609 |
| 2022 | 54 | 1 | 17 | $3,560 |
See the largest Medicaid services in earlier years
2023
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 203 | $14,448 |
| EMERGENCY DEPT VISIT LOW MDM | 126 | $5,160 |
2022
| EMERGENCY DEPARTMENT VISIT STRAIGHTFORWARD MDM | 54 | $3,560 |
Drugs they prescribed that Part D paid
$12,013
Pharmacies billed $12,013 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 238) in 2024. At or below the middle of the specialty; the typical ophthalmology clinician is at 0%.
178 generic and 60 brand-name prescriptions · $12,013 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Prednisolone Acetate | 47 | $1,509 | $32 |
| Dorzolamide-Timolol | 32 | $438 | $14 |
| Neomycin-Polymyxin-Dexameth | 31 | $330 | $11 |
| Valacyclovir | 11 | $268 | $24 |
| Ketorolac Tromethamine | 14 | $237 | $17 |
See all 6 drugs
| Prednisolone Acetate | 47 | $1,509 | $32 |
| Dorzolamide-Timolol | 32 | $438 | $14 |
| Neomycin-Polymyxin-Dexameth | 31 | $330 | $11 |
| Valacyclovir | 11 | $268 | $24 |
| Ketorolac Tromethamine | 14 | $237 | $17 |
| Brimonidine | 24 | $149 | $6 |
Year by year
| 2024 | 238 | 107 | 0% (0) | 25% | $12,013 |
| 2023 | 233 | 100 | 0% (0) | 25% | $23,615 |
| 2022 | 505 | 163 | 0% (0) | 36% | $45,144 |
| 2021 | 678 | 233 | 0% (0) | 38% | $54,580 |
| 2020 | 554 | 205 | 0% (0) | 30% | $32,777 |
| 2019 | 110 | 57 | 0% (0) | 24% | $7,165 |
| 2018 | 25 | 12 | 0% (0) | None | $1,114 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Restasis | 12 | $8,370 | $698 |
| Dorzolamide-Timolol | 27 | $875 | $32 |
| Prednisolone Acetate | 15 | $731 | $49 |
| Brimonidine | 26 | $608 | $23 |
| Neomycin-Polymyxin-Dexameth | 22 | $366 | $17 |
| Latanoprost | 25 | $320 | $13 |
| Erythromycin | 13 | $146 | $11 |
2022: 10 drugs
| Prednisolone Acetate | 100 | $5,884 | $59 |
| Rhopressa | 14 | $4,812 | $344 |
| Simbrinza | 15 | $3,099 | $207 |
| Dorzolamide-Timolol | 41 | $1,418 | $35 |
| Ketorolac Tromethamine | 53 | $1,272 | $24 |
| Latanoprost | 41 | $968 | $24 |
| Brimonidine | 21 | $958 | $46 |
| Erythromycin | 50 | $637 | $13 |
| Polymyxin B Sul-Trimethoprim | 57 | $532 | $9 |
| Timolol Maleate | 14 | $159 | $11 |
2021: 13 drugs
| Prednisolone Acetate | 114 | $6,310 | $55 |
| Rhopressa | 16 | $4,593 | $287 |
| Alphagan P | 12 | $3,576 | $298 |
| Simbrinza | 18 | $3,245 | $180 |
| Travoprost | 17 | $2,466 | $145 |
| Dorzolamide-Timolol | 59 | $2,245 | $38 |
| Latanoprost | 93 | $1,317 | $14 |
| Ketorolac Tromethamine | 46 | $1,228 | $27 |
| Brimonidine | 34 | $866 | $25 |
| Dorzolamide | 21 | $658 | $31 |
| Polymyxin B Sul-Trimethoprim | 57 | $466 | $8 |
| Erythromycin | 37 | $392 | $11 |
| Bacitracin-Polymyxin | 16 | $250 | $16 |
2020: 12 drugs
| Rhopressa | 13 | $3,537 | $272 |
| Alphagan P | 12 | $3,529 | $294 |
| Brimonidine | 43 | $2,090 | $49 |
| Prednisolone Acetate | 58 | $2,038 | $35 |
| Dorzolamide-Timolol | 42 | $1,533 | $37 |
| Erythromycin | 75 | $1,089 | $15 |
| Latanoprost | 73 | $868 | $12 |
| Valacyclovir | 14 | $824 | $59 |
| Moxifloxacin | 17 | $645 | $38 |
| Dorzolamide | 14 | $572 | $41 |
| Bacitracin-Polymyxin | 30 | $367 | $12 |
| Polymyxin B Sul-Trimethoprim | 15 | $111 | $7 |
2019: 2 drugs
| Erythromycin | 22 | $338 | $15 |
| Latanoprost | 12 | $224 | $19 |
Money from drug and device companies
$864 in 2025
| 2025 | 10 | 21 | None | $864 |
| 2024 | 8 | 18 | None | $796 |
| 2023 | 4 | 4 | None | $318 |
| 2022 | 4 | 9 | None | $892 |
| 2021 | 2 | 6 | None | $470 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Regeneron Pharmaceuticals | Eylea Hd | $183 | 3 payments
|
| Astellas Pharma Global Development | Izervay | $153 | 1 payment
|
| Genentech USA | Vabysmo | $136 | 4 payments
|
| ANI Pharmaceuticals | Iluvien | $126 | 5 payments
|
| Regeneron Healthcare Solutions | Eylea Hd | $105 | 3 payments
|
| Mallinckrodt Hospital Products | Acthar | $39 | 1 payment
|
See all 21 published payments
| Regeneron Healthcare Solutions | Meals · 2025-12-15 | Eylea Hd | $37 |
| Regeneron Pharmaceuticals | Meals · 2025-12-04 | Eylea Hd | $131 |
| Mallinckrodt Hospital Products | Meals · 2025-11-20 | Acthar | $39 |
| ANI Pharmaceuticals | Meals · 2025-11-12 | Iluvien | $32 |
| Regeneron Pharmaceuticals | Meals · 2025-11-07 | Eylea Hd | $26 |
| Genentech USA | Meals · 2025-10-24 | Vabysmo | $27 |
| Harrow Eye | Meals · 2025-09-15 | Triesence | $36 |
| ANI Pharmaceuticals | Meals · 2025-09-09 | Iluvien | $23 |
| ANI Pharmaceuticals | Meals · 2025-09-02 | Iluvien | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-08-04 | Eylea Hd | $33 |
| Astellas Pharma Global Development | Meals · 2025-06-22 | Izervay | $153 |
| Apellis Pharmaceuticals | Meals · 2025-06-16 | Syfovre | $29 |
| Regeneron Pharmaceuticals | Meals · 2025-06-04 | Eylea Hd | $26 |
| ANI Pharmaceuticals | Meals · 2025-05-20 | Yutiq | $23 |
| Regeneron Healthcare Solutions | Meals · 2025-05-07 | Eylea Hd | $34 |
| Genentech USA | Meals · 2025-04-29 | Vabysmo | $33 |
| Genentech USA | Meals · 2025-04-09 | Susvimo | $47 |
| Astellas Pharma US | Meals · 2025-03-14 | Izervay | $35 |
| Abbvie | Meals · 2025-02-25 | Ozurdex | $22 |
| Genentech USA | Meals · 2025-02-21 | Vabysmo | $29 |
| ANI Pharmaceuticals | Meals · 2025-01-28 | Purified Cortrophin Gel | $25 |
See earlier years (2024, 2023, 2022, 2021)
2024: $796
| Astellas Pharma US | Izervay | $276 | 6 payments
|
| Alcon Vision | Constellation | $173 | 3 payments
|
| EyePoint Pharmaceuticals US | None | $125 | 1 payment
|
| Apellis Pharmaceuticals | Syfovre | $63 | 2 payments
|
| Genentech USA | Vabysmo | $55 | 2 payments
|
| Oyster Point Pharma | Tyrvaya | $51 | 2 payments
|
| Regeneron Healthcare Solutions | Eylea Hd | $31 | 1 payment
|
| Mallinckrodt Hospital Products | Acthar | $23 | 1 payment
|
2023: $318
| Regeneron Healthcare Solutions | Eylea Hd | $134 | 1 payment
|
| Astellas Pharma US | None | $111 | 1 payment
|
| Alcon Vision | Ngenuity | $54 | 1 payment
|
| AbbVie | Ozurdex | $19 | 1 payment
|
2022: $892
| Alcon Vision | Clareon | $600 | 6 payments
|
| Regeneron Healthcare Solutions | Eylea | $130 | 1 payment
|
| Alimera Sciences | Iluvien | $86 | 1 payment
|
| Glaukos | Iaccess | $77 | 1 payment
|
2021: $470
| Alcon Vision | Acrysof Iq Vivity Iol | $323 | 4 payments
|
| Allergan | Durysta | $146 | 2 payments
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 81.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1194220632
- Licence
- FL ME154746Florida ME154746: Active
- Trained
- University of Miami, Lm Miller School of Medicine, 2018
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207W00000X (207W00000X); Federal specialty code 207WX0107X (207WX0107X)
- Mailing address
- 3395 S Bascom Ave, Campbell, CA, 95008
- NPI first listed
- 2018-03-27
- NPI last updated
- 2024-08-02
- NPI record certified
- 2024-08-02
This is when the NPI record was last certified, not a medical board exam.